View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 11, 2018

Medtronic begins study for spinal cord stimulation programming

Medtronic has started enrolment in the Vectors Post Market Clinical Study to evaluate optimised spinal cord stimulation (SCS) programming for standardised delivery of treatment.

Medtronic has started enrolment in the Vectors Post Market Clinical Study to evaluate optimised spinal cord stimulation (SCS) programming for standardised delivery of treatment.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The study will recruit patients suffering from chronic intractable pain and undergoing SCS treatment that is managed using the Evolve workflow.

Evolve, which is powered by Medtronic SCS systems such as implantable Intellis neurostimulator, standardises guidance for balancing high and low-dose therapy settings to aid optimised treatment.

The prospective, multi-centre Vectors study will investigate SCS’ long-term efficacy and impact on quality of life in around 175 subjects at up to 25 US sites.

The study also aims to validate the Evolve workflow by assessing the effectiveness and potential benefits for patients having access to high and low-dose stimulation modalities.

“This data may help us expand our ability to help people struggling with chronic intractable pain.”

Vectors study primary investigator John Hathaway said: “The Vectors study will generate meaningful data about the use of the Evolve workflow and will help further physicians’ understanding of how to use this simple, versatile approach to enable effective, long-term pain relief with SCS.

“Knowing how to best use non-opioid treatment options like the Intellis SCS platform is more important than ever, and this data may help us expand our ability to help people struggling with chronic intractable pain.”

Medtronic’s neurostimulation therapy for chronic intractable pain involves implantation of a medical device to deliver mild electrical impulses for blocking transmission of pain signals to the brain.

According to the data from different clinical trials, SCS offers better pain relief compared to re-operation and standard medical management.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network